As of 2025-03-17, the EV/EBITDA ratio of Genomic Vision SA (GV.PA) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GV.PA's latest enterprise value is 1.66 mil EUR. GV.PA's TTM EBITDA according to its financial statements is -7.39 mil EUR. Dividing these 2 quantities gives us the above GV.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 10.1x | 9.8x |
| Forward P/E multiples | 9.6x - 10.1x | 9.8x |
| Fair Price | (0.19) - (0.20) | (0.19) |
| Upside | -10447.5% - -10979.1% | -10713.3% |
| Date | EV/EBITDA |